Fox NewsHealth
Drug combo shrinks pancreatic tumors in most patients

The pancreatic cancer pill daraxonrasib shrank tumors in 60.7 percent of patients when combined with chemotherapy. Scans showed no visible tumors in 8.2 percent, offering a promising result for people facing this aggressive cancer type.
This card is an AI-assisted summary of reporting published by Fox News. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.